François Loubignac

François Loubignac

orcid

Research Focus & Metrics

Academic Career Length

30Years (1997-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2010 in Orthopaedics & Traumatology: Surgery & Research
Verified
Journal Article
Closed access
TJTONETTI JEROME
TONETTI JEROME
SRS. Ruatti
S. Ruatti
VLV. Lafontan
V. Lafontan
FLFrançois Loubignac
François Loubignac
PCP. Chiron
P. Chiron
PBP. Bonnevialle
P. Bonnevialle

1 October 2012 in Orthopaedics & Traumatology: Surgery & Research
Verified
Journal Article
Closed access
PBP. Bonnevialle
P. Bonnevialle
FBF. Bonnomet
F. Bonnomet
RPR. Philippe
R. Philippe
FLFrançois Loubignac
François Loubignac
BRB. Rubens-Duval
B. Rubens-Duval
PAP. Adam
P. Adam

1 January 2015 in Injury
Verified
Journal Article
Closed access
HNH. Niéto
H. Niéto
ABA. Billaud
A. Billaud
SRS. Rochet
S. Rochet
NLN. Lavoinne
N. Lavoinne
FLFrançois Loubignac
François Loubignac
TFT. Fabre
T. Fabre

22 April 2009 in World Journal of Surgical Oncology
Verified
Journal Article
Open access
PDF file
FLFrançois Loubignac
François Loubignac
CBChristophe Bourtoul
Christophe Bourtoul
FCFrancoise Chapel
Francoise Chapel
Lipoma is by far the most common of all benign soft-tissue tumors which far outnumber malignant tumors. Soft-tissue sarcomas are malignant tumors and are usually named for the type of tissue in which they begin. Liposarcoma (LPS), which arises in the fatty tissue, is rather an uncommon soft-tissue tumor. Multiple histologic subtypes of liposarcoma are recognized, including myxoid liposarcoma, and correspond to tumors of very different prognosis. In two-third of the cases, this tumor occurs in the muscle while often demonstrating a misleading benign appearance as observed in the majority of soft-tissue sarcomas.

13 January 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
EGEnrique Gómez-Barrena
Enrique Gómez-Barrena
TWTimothy Warren
Timothy Warren
IWIan Walker
Ian Walker
NJNeil Jain
Neil Jain
NKNanne Kort
Nanne Kort
BTBasilio de la Torre
Basilio de la Torre
Periprosthetic joint infection (PJI) is a devastating complication in total hip and knee replacement. Its prevention is key to decrease the incidence and avoid some consequences that seriously impact patients and health systems. In view of the variety of recommendations and guidelines, we decided to conduct an expert, peer-reviewed European consensus analysis about the pre-, intra-, and postoperative prevention of PJI. A multinational group of practicing orthopedic experts developed a series of 47 consensus statements in 6 main groups of intervention, and a 2-stage Delphi approach was launched with a threshold for agreement at 75% and for very high agreement at more than 90%. A total of 306 orthopedic surgeon responses were gathered from 9 countries. Consensus was reached for 42/47 statements, 31/47 of which achieved a very high consensus. Many preoperative actions gathered strong consensus, although areas like the use of alcoholic chlorhexidine or the timing of hair removal did not attain strong consensus, despite available evidence. Intra- and postoperative actions showed more variability regarding incise drapes, skin suturing techniques, and wound follow-up. This study confirms an important consensus among orthopedic surgeons across Europe in many areas well known to contribute to the prevention of PJI; however, there are still grounds for improvement.

1 April 2009 in Orthopaedics & Traumatology: Surgery & Research
Verified
Journal Article
Closed access
FLFrançois Loubignac
François Loubignac
JCJ.-F. Chabas
J.-F. Chabas